lumbrokinase supplier

Lumbrokinase/Earthworm extract

556743-18-1
Product Name: Lumbrokinase/Earthworm extract
Product Code:HWSW239
Appearance:White powder
Specification:98%
Test method:HPLC/UV
Certificates:ISO,FDA,HACCP,HALAL,KOSHER,etc.
Product grade:Food Grade
Strorage:Sealed and protected from light at room temperature.
Delivery:Shipped on the same day from stocks.
MOQ:1KG
 
Product Name
Lumbrokinase/Earthworm extract
Appearance
White powder 
Specification
5000iu/g-20000iu/g
Test Method
HPLC
Storage
Keep in a cool, dry, dark location in a tightly sealed container or cylinder.
Shelf Time
24 months 
 
Lumbrokinase, also known as protein hydrolase, Bolucke, Lumbrokinasum, is a group of protein hydrolase enzymes extracted from special earthworms (e.g., captive red earthworms), which are acidic proteins with a molecular weight of 16,000-45,000D.
 Xi'an Huawave Biotech Co., Ltd. is a professional Lumbrokinase manufacturer and Lumbrokinasesupplier . We are committed to providing customers with professional research and development, production and sales, as well as OEM and ODM processing services.
 
     

1. Thrombolytic Function

Lumbrokinase demonstrates significant thrombolytic effects. It contains plasminogen activator and plasmin, which can directly act on blood clots to promote the dissolution of fibrinogen, thereby effectively reducing the formation of blood clots. Clinical studies have shown that lumbrukinase can reduce fibrinogen levels, shorten euglobulin lysis time, and decrease whole blood viscosity and plasma viscosity, further confirming its thrombolytic properties.

2. Neuroprotective Function

In the treatment of patients with acute cerebral infarction, Lumbrokinase exhibits neuroprotective effects. By lowering serum neuron-specific enolase (NSE) levels, lumbrukinase can mitigate neuronal damage and improve neurological impairment. This discovery provides strong support for the application of lumbrukinase in neuroprotection.

3. Prevention of Recurrent Atherosclerotic Cerebral Infarction

Lumbrokinase also shows significant effects in the secondary prevention of atherosclerotic cerebral infarction. Clinical studies have indicated that patients treated with lumbrukinase have a significantly reduced recurrence rate of ischemic stroke and a lower incidence of cardiovascular events. This finding provides an important basis for the application of lumbrukinase in preventing recurrent cerebral infarction.

1. Thrombolytic Therapy

  • Lumbrokinase is recognized for its ability to dissolve blood clots, making it a valuable option in thrombolytic therapy.
  • It works by directly hydrolyzing fibrin and indirectly by activating plasminogen into plasmin, thereby promoting the dissolution of blood clots.

2. Treatment of Cardiovascular and Cerebrovascular Diseases

  • Lumbrokinase is used to treat a range of cardiovascular and cerebrovascular diseases, including cerebral infarction, coronary heart disease, and angina pectoris.
  • By improving blood circulation and reducing the formation of blood clots, it helps to alleviate symptoms and prevent further complications.

3. Prevention of Atherosclerosis

  • Lumbrokinase has been shown to have a preventive effect on atherosclerosis by reducing fibrinogen levels and inhibiting platelet aggregation.
  • This makes it a potential option for individuals at risk of developing atherosclerosis or those seeking to manage the condition.

4. Improving Microcirculation

  • Lumbrokinasex can improve microcirculation by reducing blood viscosity and enhancing blood flow.
  • This is beneficial for individuals with circulatory issues or those seeking to improve their overall cardiovascular health.